MESO - Mesoblast Ltd - ADR
IEX Last Trade
6.74
0.270 4.006%
Share volume: 111,497
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.47
0.27
4.17%
Summary score
11%
Profitability
0%
Dept financing
7%
Liquidity
27%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.39%
Return on assets
-2.77%
Return on sales
-2458.58%
Return on invested capital
-2.93%
Total debt ratio
27.92%
Debt ratio change over timeo
-10.77%
Current Ratio
2.37%
Quick Ratio
0%
Cash Position Ratio
1.61%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.8%
Return on assets
-2.5%
Return on sales
-1486.49%
Return on invested capital
-3.44%
Total debt ratio
30.21%
Debt ratio change over timeo
-15.7%
Current Ratio
1.12%
Quick Ratio
0%
Cash Position Ratio
0.78%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.04%
Return on assets
-4.02%
Return on sales
-4574.46%
Return on invested capital
-5.67%
Total debt ratio
32.41%
Debt ratio change over time
-12.27%
Current Ratio
1.51%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
2.65%
Return on assets
-9.53%
Return on sales
63318.4%
Return on invested capital
-12.63%
Total debt ratio
-1076.89%
Debt ratio change over time
-10.77%
Current Ratio
-75.6%
Quick Ratio
0%
Cash Position Ratio
-66.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MESO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.39% | -3.05% | 11.55% | 6.27% |
| Return on assets | -2.77% | 3.6% | 3.57% | 5.27% |
| Return on sales | -2458.58% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -2.93% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 27.92% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -10.77% | 6.09% | 6.03% | 1.53% |
| Dept financing | 7% | 50% | 43% | 14% |
| Current Ratio | 1.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.78% | 1.48% | 0.76% | 1.49% |
| Liquididy | 41% | 32% | 59% | 68% |
| Short-term ratios | MESO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.8% | -25.62% | 17.94% | 7.14% |
| Return on assets | -2.5% | 3.26% | 3.67% | 4.71% |
| Return on sales | -1486.49% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -3.44% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 30.21% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -15.7% | -23.44% | 9.66% | 0.6% |
| Dept financing | 7% | 25% | 45% | 8% |
| Current Ratio | 1.12% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.78% | 1.48% | 0.76% | 1.49% |
| Liquididy | 21% | 57% | 42% | 75% |